Publications
42
Citations
1,289
Est. group size
~1
Recurring co-author estimate
Active years
41
Publishing since 1986
Wael Jarjour's research focuses on autoimmune and inflammatory diseases such as systemic lupus erythematosus, rheumatoid arthritis, and Sjögren's syndrome, with attention to the immune cells (T-cells and B-cells) and antibodies involved in these conditions. Recent work has explored potential therapies, including stem-cell-based treatments and hormone-receptor-targeting drugs, aimed at reducing harmful immune system activity in these diseases.
Publication output has been irregular over the past decade, with gaps in some years, a peak in 2020, and a recent uptick in 2025-2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- ABS0009 THE ERß AGONIST, WT-IV-012, SUPRESSES THE INFLAMMATORY RESPONSE IN SYSTEMIC LUPUS ERYTHEMATOSUS
Annals of the Rheumatic Diseases · 2025
- Therapeutic Effect of Mesenchymal Stem Cells on Sjögren's Syndrome: Systematic Review and a Preclinical Meta-Analysis
Research Square · 2021
- Human gingiva-derived mesenchymal stem cells ameliorate rheumatoid arthritis through directly targeting of rheumatoid arthritis synovial fibroblasts
The Journal of Immunology · 2020
- The Journal of Immunology×3
- Elsevier eBooks×2
- Annals of the Rheumatic Diseases×2
- iScience×1
- Frontiers in Immunology×1
- Wael N. Jarjour
Medicine · The Ohio State University
- Huijuan Song
Medicine · The Ohio State University
- B.H. Rovin
Medicine · The Ohio State University
- E. Grau Garcia
Medicine · Indiana University
- Haichang Li
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile